[Guidelines for the management of rheumatoid arthritis].
In 2014, guidelines for the management of rheumatoid arthritis, was announced from Japan College of Rheumatology. This guideline was made by the GRADE (Grading of Recommendations Assessment, Development and Evaluation) method with a concept of "treat to target" led for European and American recommendation of rheumatoid arthritis. It assesses not only evidences but also the balance of desirable and undesirable consequences, values and preferences of the patient, and resource use. It is constructed by evidence summary of 88 clinical questions and 37 recommendations about medication, orthopaedic surgery and rehabilitation.
Yutaka
Y
Kawahito
D000069594:Abatacept / Q000008:administration & dosage; D000465:Algorithms; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D018501:Antirheumatic Agents / Q000008:administration & dosage; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000534:rehabilitation / Q000601:surgery; D001688:Biological Products / Q000008:administration & dosage; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D006801:Humans; D007564:Japan; D008727:Methotrexate / Q000008:administration & dosage; D010880:Piperidines / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D011743:Pyrimidines / Q000008:administration & dosage; D011758:Pyrroles / Q000008:administration & dosage
D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D001688:Biological Products; D010880:Piperidines; D011743:Pyrimidines; D011758:Pyrroles; D000069594:Abatacept; C479163:tofacitinib; C502936:tocilizumab; D008727:Methotrexate